Payment overview · 2025
General Payments
$142.27
2 reported records · 2 companies
Healthcare provider profile · identity verified
Patrick R Vandehey, DO
Allopathic & Osteopathic Physicians|Family Medicine · ALLEN PARK, MI · NPI 1568544880
Verified facts
What the public records show
CMS Open Payments records show Patrick R Vandehey, DO received $142.27 in general payments during 2025 across 2 reported records.
PFIZER INC. accounted for 87.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Synthroid by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 97 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $125.00 | 87.9% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $17.27 | 12.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $142.27 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $125.00 | 1 | 2025 |
Source payment records
|
|||||
| BOTOX Normalized: botox |
Biological | ABBVIE INC. | $17.27 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
31 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
97 | 31 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
16 | 16 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 615 | 179 |
| Levothyroxine Sodium | Levothyroxine Sodium | 514 | 140 |
| Losartan Potassium | Losartan Potassium | 413 | 111 |
| Amlodipine Besylate | Amlodipine Besylate | 402 | 109 |
| Omeprazole | Omeprazole | 376 | 114 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 367 | 71 |
| Lisinopril | Lisinopril | 345 | 97 |
| Metoprolol Succinate | Metoprolol Succinate | 345 | 88 |
| Alprazolam | Alprazolam | 286 | 69 |
| Gabapentin | Gabapentin | 285 | 67 |
| Pantoprazole Sodium | Pantoprazole Sodium | 268 | 74 |
| Metformin Hcl | Metformin Hcl | 258 | 76 |
| Tamsulosin Hcl | Tamsulosin Hcl | 234 | 70 |
| Hydrochlorothiazide | Hydrochlorothiazide | 229 | 66 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 197 | 65 |
| Methylprednisolone | Methylprednisolone | 183 | 142 |
| Ibuprofen | Ibuprofen | 167 | 51 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 164 | 53 |
| Metoprolol Tartrate | Metoprolol Tartrate | 162 | 49 |
| Meloxicam | Meloxicam | 159 | 44 |
| Clopidogrel | Clopidogrel Bisulfate | 145 | 38 |
| Simvastatin | Simvastatin | 141 | 39 |
| Tramadol Hcl | Tramadol Hcl | 141 | 34 |
| Furosemide | Furosemide | 140 | 48 |
| Potassium Chloride | Potassium Chloride | 133 | 41 |
| Escitalopram Oxalate | Escitalopram Oxalate | 122 | 36 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 121 | 27 |
| Montelukast Sodium | Montelukast Sodium | 120 | 35 |
| Allopurinol | Allopurinol | 119 | 35 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 116 | 32 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 115 | 28 |
| Mounjaro | Tirzepatide | 114 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 111 | 33 |
| Zolpidem Tartrate | Zolpidem Tartrate | 108 | 21 |
| Diazepam | Diazepam | 105 | 30 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 103 | 29 |
| Fluticasone Propionate | Fluticasone Propionate | 101 | 37 |
| Eliquis | Apixaban | 97 | 31 |
| Sertraline Hcl | Sertraline Hcl | 96 | 24 |
| Pravastatin Sodium | Pravastatin Sodium | 89 | 22 |
| Carvedilol | Carvedilol | 87 | 25 |
| Trazodone Hcl | Trazodone Hcl | 87 | 27 |
| Glimepiride | Glimepiride | 80 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 80 | 20 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 76 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 76 | 19 |
| Famotidine | Famotidine | 73 | 23 |
| Ozempic | Semaglutide | 69 | 15 |
| Doxycycline Hyclate | Doxycycline Hyclate | 68 | 56 |
| Jardiance | Empagliflozin | 66 | 17 |
| Azithromycin | Azithromycin | 65 | 53 |
| Bumetanide | Bumetanide | 63 | 17 |
| Finasteride | Finasteride | 62 | 23 |
| Alendronate Sodium | Alendronate Sodium | 61 | 20 |
| Atenolol | Atenolol | 61 | 18 |
| Metformin Hcl Er | Metformin Hcl | 61 | 15 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 59 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 59 | 46 |
| Diclofenac Sodium | Diclofenac Sodium | 59 | 18 |
| Pregabalin | Pregabalin | 58 | 15 |
| Ramipril | Ramipril | 57 | 13 |
| Temazepam | Temazepam | 57 | 14 |
| Prednisone | Prednisone | 56 | 34 |
| Clonazepam | Clonazepam | 54 | 17 |
| Donepezil Hcl | Donepezil Hcl | 54 | 20 |
| Hydralazine Hcl | Hydralazine Hcl | 54 | 13 |
| Lactulose | Lactulose | 54 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 53 | 21 |
| Celecoxib | Celecoxib | 51 | suppressed |
| Januvia | Sitagliptin Phosphate | 50 | 15 |
| Novolog Flexpen | Insulin Aspart | 50 | 12 |
| Bupropion Xl | Bupropion Hcl | 48 | 15 |
| Dicyclomine Hcl | Dicyclomine Hcl | 47 | 13 |
| Lorazepam | Lorazepam | 47 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 47 | 13 |
| Buspirone Hcl | Buspirone Hcl | 46 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 46 | 35 |
| Ropinirole Hcl | Ropinirole Hcl | 45 | 11 |
| Fluconazole | Fluconazole | 43 | 23 |
| Fenofibrate | Fenofibrate | 42 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 42 | 12 |
| Trulicity | Dulaglutide | 41 | 12 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 40 | 23 |
| Ventolin Hfa | Albuterol Sulfate | 40 | 18 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 39 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 39 | suppressed |
| Chlorthalidone | Chlorthalidone | 38 | suppressed |
| Lamotrigine | Lamotrigine | 37 | 11 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 37 | 18 |
| Valacyclovir | Valacyclovir Hcl | 37 | 20 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 36 | 15 |
| Mirtazapine | Mirtazapine | 36 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 35 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 35 | suppressed |
| Ezetimibe | Ezetimibe | 34 | 12 |
| Ibu | Ibuprofen | 34 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 34 | 30 |
| Klor-Con M20 | Potassium Chloride | 33 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 32 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 31 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 31 | 11 |
| Rybelsus | Semaglutide | 31 | suppressed |
| Synthroid | Levothyroxine Sodium | 31 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 30 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 30 | suppressed |
| Xarelto | Rivaroxaban | 30 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 29 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 29 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 29 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 29 | 11 |
| Topiramate | Topiramate | 29 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 26 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 25 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 25 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 25 | suppressed |
| Hydrocortisone | Hydrocortisone | 25 | 15 |
| Memantine Hcl | Memantine Hcl | 25 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 25 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 24 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 24 | suppressed |
| Naproxen | Naproxen | 24 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 24 | 13 |
| Ondansetron Odt | Ondansetron | 23 | suppressed |
| Sucralfate | Sucralfate | 23 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 22 | suppressed |
| Ketoconazole | Ketoconazole | 22 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 22 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 22 | suppressed |
| Valsartan | Valsartan | 22 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 22 | suppressed |
| Baclofen | Baclofen | 21 | suppressed |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 21 | suppressed |
| Methocarbamol | Methocarbamol | 21 | 16 |
| Mupirocin | Mupirocin | 21 | 16 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 21 | suppressed |
| Cephalexin | Cephalexin | 20 | 17 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 20 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 20 | suppressed |
| Spironolactone | Spironolactone | 20 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Verapamil Er | Verapamil Hcl | 20 | suppressed |
| Digoxin | Digoxin | 19 | suppressed |
| Glipizide | Glipizide | 19 | suppressed |
| Halobetasol Propionate | Halobetasol Propionate | 19 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 18 | 13 |
| Acyclovir | Acyclovir | 17 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 17 | suppressed |
| Entresto | Sacubitril/Valsartan | 17 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | 16 |
| Tresiba Flextouch U-200 | Insulin Degludec | 17 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 17 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 16 | suppressed |
| Levetiracetam | Levetiracetam | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 16 |
| Piroxicam | Piroxicam | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Estradiol | Estradiol | 15 | suppressed |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | 12 |
| Midodrine Hcl | Midodrine Hcl | 15 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 15 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 15 | suppressed |
| Glyburide | Glyburide | 14 | suppressed |
| Humalog Kwikpen U-200 | Insulin Lispro | 14 | suppressed |
| Methotrexate | Methotrexate Sodium | 14 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 14 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 12 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 12 | suppressed |
| Jantoven | Warfarin Sodium | 12 | suppressed |
| Latanoprost | Latanoprost | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 12 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 12 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Klor-Con M10 | Potassium Chloride | 11 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $142.27 · 2 records | PFIZER INC. | BOTOX, ZAVZPRET | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error